Chemical substances
1. Core Advantages
Relying on the OECD GLP zero-defect certification qualification, chemical test data can be universally recognized worldwide, simultaneously complying with both domestic and international chemical regulatory laws as well as relevant requirements of the Ministry of Ecology and Environment. This efficiently supports needs such as chemical registration and export declarations. As the only institution in the Northwest region to have obtained OECD GLP certification, we fill a gap in the high-end chemical GLP evaluation sector in western China. Our qualifications boast industry-leading authority and compliance alignment, and the reports we issue directly meet cross-border declaration requirements, eliminating the need for repeated testing and reducing enterprises’ declaration costs by more than 30%.
2. Scope of Services
The services include safety assessments of new chemical substances, toxicological testing of chemicals (such as acute oral/dermal/inhalation toxicity tests, skin/eye irritation tests, skin sensitization tests, subchronic toxicity tests, and teratogenicity tests), as well as quality testing of chemical raw materials and finished products. The resulting test reports can be directly used for registration, market launch, and cross-border declarations, meeting the regulatory requirements of multiple government departments.
3. Research Experience
With years of deep expertise in the field of GLP evaluation for chemicals, we have cumulatively completed numerous chemical safety assessment services and boast extensive practical experience. Relying on a professional experimental platform and a top-notch technical team, we have successfully supported the completion of numerous chemical evaluation projects and achieved application approval rates significantly above the industry average. Our services cater to mainstream chemical manufacturers across China, helping our sponsor efficiently pass regulatory reviews, accelerate product commercialization, and expedite their entry into overseas markets.
More fields
As an institution in Shaanxi Province that has obtained NMPA drug GLP certification and completed its qualification re-examination and scope expansion in 2024, Guorui Yinuo has built a “global + domestic” dual-compliance service capability in the pharmaceutical sector.
The one-stop service platform for veterinary drugs—GLP/GCP—is a specialized service provider that offers an integrated solution—from non-clinical evaluation to clinical trials and registration submission—aligned with both the Ministry of Agriculture and Rural Affairs’ GLP/GCP standards for veterinary drugs and the international OECD GLP standards, covering the entire R&D process for veterinary pharmaceuticals. At its core, this platform addresses the key pain points faced by companies, including long R&D cycles, high compliance barriers, and fragmented resources.
As the only organization in the Northwest region to have obtained OECD GLP certification in the pesticide field, Guorui Yinuo passed the international assessment with a zero-defect record. Relying on its compliance credentials, comprehensive technological capabilities across the entire value chain, and high-standard laboratory platform, Guorui Yinuo provides integrated solutions for global pesticide companies—from research and development all the way through registration.
Relying on the OECD GLP zero-defect certification qualification, chemical test data can be globally recognized and simultaneously comply with both domestic and international chemical regulatory requirements as well as relevant requirements of the Ministry of Ecology and Environment, efficiently supporting needs such as chemical registration and export declarations.
Shaanxi Guorui Xinchuang Medical Technology Co., Ltd. is an independent, third-party clinical preclinical safety evaluation research institution for medical devices. It was registered and established in June 2020 in the Airport New City and is currently the most comprehensive medical device safety evaluation institution in Northwest China. The company primarily provides product safety evaluation services to R&D enterprises specializing in Class II and Class III medical devices.
A full-process technology empowerment platform from target discovery to IND submission
Early Toxicity Prediction and Screening
Early toxicity screening is an essential and indispensable step in the new drug development process. Early termination of compounds that show no development potential can save sponsor substantial amounts of manpower, resources, and time. We offer sponsor comprehensive early toxicity screening services, including early genotoxicity assessment, early general toxicity assessment, and early reproductive and developmental toxicity assessment.
We are equipped with specialized instruments and devices, including flow cytometers, microplate readers, fluorescence microscopes, and PCR machines. These resources enable us to establish animal models for diseases affecting the tumor, cardiovascular, respiratory, metabolic, and urinary systems, and to conduct comprehensive and systematic preclinical studies on drug efficacy and mechanisms at multiple levels.
Contact phone number
Ms. Li:+86 15760970681
Mr. Su:+86 19991001701
Landline:+86-29-33656828
Company Address
4th Floor, Unit C. Building 9. Small and Medium-sized
Enterprise Park, Airport Industrial Zone Airport New Ciy,Xixian New Area, Shaanxi Province
©2026 Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd.
WhatsApp：8613940397353
Email：hr-xian@grglp.com
Landline：862933656828
Mr. Su：8619991001701
Ms. Li：8615760970681